Safety and Efficacy of Bispecific Antibodies, ADCs and Combination Therapy

The PepTalk Summit will review clinical successes and milestones of emerging constructs and novel formats for these important assets in the drug development arsenal. The safety and efficacy of bispecifics and ADCs will be examined for molecules in development, and strategies and trends will be shared that address and mitigate toxicity issues.

Event Contact
Address: San Diego, USA
Phone: TBC
Email: clingham@healthtech.com
Organizer
1. Medical 2. Research 3. Biotech 4. Education 5. Conferences
At Cambridge Healthtech Institute (CHI), we believe bringing together a unique and diverse constellation of innovators, scientists, and life science professionals can hold the key to developing tomorrow’s cures and diagnostics.
gen-logo
Sign in to your account